Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
![Abbott Laboratories logo](/files/LOGO/1800-ABT.png)
Company profile
Ticker
ABT
Exchange
Website
CEO
Robert Ford
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Abbott Biologicals, LLC • Abbott Cardiovascular Inc. • Abbott Cardiovascular Systems Inc. • Abbott Delaware LLC • Abbott Diabetes Care Inc. • Abbott Diabetes Care Sales Corporation • Abbott Diagnostics Scarborough, Inc. • Abbott Equity Investments LLC • Abbott Finance LLC • Abbott Global LLC ...
IRS number
360698440
ABT stock data
Latest filings (excl ownership)
8-K
Abbott Reports Second-Quarter 2024 Results and Raises
18 Jul 24
SD
Conflict minerals disclosure
30 May 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
Departure of Directors or Certain Officers
1 May 24
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 24
8-K
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
17 Apr 24
ARS
2023 FY
Annual report to shareholders
15 Mar 24
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
10-K
2023 FY
Annual report
16 Feb 24
Transcripts
ABT
Earnings call transcript
2024 Q2
18 Jul 24
ABT
Earnings call transcript
2024 Q1
17 Apr 24
ABT
Earnings call transcript
2023 Q4
24 Jan 24
ABT
Earnings call transcript
2023 Q3
18 Oct 23
ABT
Earnings call transcript
2023 Q2
20 Jul 23
ABT
Earnings call transcript
2023 Q2
20 Jul 23
ABT
Earnings call transcript
2023 Q1
19 Apr 23
ABT
Earnings call transcript
2022 Q4
25 Jan 23
ABT
Earnings call transcript
2022 Q3
19 Oct 22
ABT
Earnings call transcript
2022 Q2
20 Jul 22
Latest ownership filings
4
Louis H. Morrone
2 Jul 24
4
John G Stratton
2 Jul 24
4
Michael F Roman
2 Jul 24
4
Patricia Paola Gonzalez
2 Jul 24
4
Robert J Alpern
2 Jul 24
11-K
Annual report of employee stock purchases
25 Jun 24
4
Jr. Robert E. Funck,
14 May 24
144
Notice of proposed sale of securities
10 May 24
4
Lisa D Earnhardt
8 May 24
144
Notice of proposed sale of securities
7 May 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn | 6.28 bn |
Cash burn (monthly) | 204.00 mm | 239.75 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 788.76 mm | 926.99 mm | n/a | n/a | n/a | n/a |
Cash remaining | 5.50 bn | 5.36 bn | n/a | n/a | n/a | n/a |
Runway (months of cash) | 26.9 | 22.3 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
72.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2772 |
Opened positions | 510 |
Closed positions | 189 |
Increased positions | 943 |
Reduced positions | 951 |
13F shares | Current |
---|---|
Total value | 137.18 tn |
Total shares | 1.26 bn |
Total puts | 8.66 mm |
Total calls | 8.41 mm |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 165.30 mm | $18.79 tn |
BLK Blackrock | 133.08 mm | $15.13 tn |
Capital Research Global Investors | 83.98 mm | $9.55 tn |
STT State Street | 74.74 mm | $8.49 tn |
Capital International Investors | 70.18 mm | $7.98 tn |
MS Morgan Stanley | 36.01 mm | $4.09 tn |
Geode Capital Management | 33.73 mm | $3.82 tn |
Wellington Management | 28.26 mm | $3.21 tn |
NTRS Northern Trust | 21.02 mm | $2.39 tn |
WFC Wells Fargo & Co. | 16.79 mm | $1.91 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | Louis H. Morrone | Common shares without par value | Payment of exercise | Dispose F | No | No | 103.91 | 556 | 57.77 k | 62,143 |
30 Jun 24 | Alpern Robert J | Stock Equivalent Units Common Shares | Grant | Acquire A | No | No | 103.91 | 75 | 7.79 k | 9,754 |
30 Jun 24 | Patricia P. Gonzalez | Stock Equivalent Units Common Shares | Grant | Acquire A | No | No | 103.91 | 317 | 32.94 k | 3,509 |
30 Jun 24 | Roman Michael F | Stock Equivalent Units Common Shares | Grant | Acquire A | No | No | 103.91 | 339 | 35.23 k | 4,009 |
30 Jun 24 | Louis H. Morrone | Common shares without par value | Payment of exercise | Dispose F | No | No | 103.91 | 269 | 27.95 k | 62,699 |
30 Jun 24 | John G Stratton | Stock Equivalent Units Common Shares | Grant | Acquire A | No | No | 103.91 | 353 | 36.68 k | 10,895 |
News
Abbott Laboratories's Options Frenzy: What You Need to Know
26 Jul 24
Peering Into Abbott Laboratories's Recent Short Interest
26 Jul 24
Behind the Scenes of Abbott Laboratories's Latest Options Trends
25 Jul 24
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
19 Jul 24
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
19 Jul 24
Press releases
Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
18 Jul 24
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
20 Jun 24
Abbott Declares 402nd Consecutive Quarterly Dividend
14 Jun 24
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
10 Jun 24
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
21 May 24